Acadia Looks to Expand Drug Beyond Parkinson’s Disease Psychosis

Discussion in 'Pharma/Biotech Companies - In the News' started by cafead, Dec 6, 2019 at 9:52 PM.

  1. cafead

    cafead Administrator
    Staff Member

    Joined:
    Nov 21, 2001
    Messages:
    32,979
    Likes Received:
    3
    via Acadia Pharmaceuticals revealed late-stage clinical data this week that could support bringing its drug for psychosis to a broader group of patients.

    article source